APPLICATIONS PUBLISHED 29 MAY 2002
Published: 1-Dec-2002
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Pharmaceutical compsns and methods for reducing the appearance of cellulite
Murad, Howard 1207840*
Hydroxyl-functionalised dendritic macromolecules in topical care cosmetic and personal care compsns
Unilever 1207841*
Strip pack
Drugtech 1207850*
Topical organic ectoparasiticidal formulations
Eli Lilly 1207851*
Controlled release oral dosage suitable for oral administration
Nostrum Pharmaceuticals 1207852*
Mixed micellar pharmaceutical delivery system and method of preparation
Generex Pharmaceuticals 1207853*
Preserved liposomes
Arch Personal Care Products 1207854*
Pharmaceutical compsn containing nabumetone
SmithKline Beecham 1207855*
Corformative methods and their products
Bradford Particle Design; Bristol-Myers Squibb 1207856*
Ciprofloxacin containing pharmaceutical products and process for the preparation thereof
Egis Gy Gyszergy 1207857*
Oral dosage forms
Gruenenthal 1207858*
Oral form of administration containing probiotic organisms
Merck Patent 1207859*
Controlled release pellet formulation
Nostrum Pharmaceuticals 1207860*
Treatment of fungal infections utilising a fungal growth medium
Johnson & Johnson 1207861*
Arthritis treatment
The University of Sheffield 1207862*
New uses for potassium channel openers, such as the treatment of epilepsy
Glaxo Group 1207863*
Compsns useful as inhibitors of ERK
Vertex Pharmaceuticals 1207864*
Delayed-reaction form of administration containing tramadol saccharinate
Gruenenthal 1207866*
Oral pharmaceutical forms of administration with a delayed action
Gruenenthal 1207867*
Pharmaceutical tramadol salts
Gruenenthal 1207868*
Antimycotic drug
Novartis 1207869*
Pharmaceutical compsns containing N-palmitolylethanolamide and use thereof in the veterinary field
Innovet Italia 1207870*
Use of thiamphenicol in the treatment of vancomycin-intermediates and multiresistant Staphylococci infections
Zambon Group 1207871*
Methods of inhibiting osteoclast activity
The Trustees of the University of Pennsylvania 1207873*
Methods of treating proliferative disorders
Biomedicines 1207874*
Pharmaceutically stable oxaplatinum preparation for parenteral administration
Debiopharm 1207875*
Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor
Max-Planck-Gesellschaft zur Foerderung der Wissenschaft 1207876*
Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids
The Brigham and Women's University 1207877*
Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
Viatris 1207878*
Nicotine receptor agonists in stem cell and progenitor cell recruitment
The Board of Trustees of the Leland Stanford University 1207879*
Torsemide polymorphs
Teva Pharmaceutical Industries 1207880*
Pharmaceutical agent comprising a benzamide derivatives as active ingredient
Schering 1207881*
Acyclic and cyclic amine derivatives
Vertex Pharmaceuticals 1207882*
Use of at least one substance based on nicotine and/or a substance produced from said one substance for the manufacture of a medicament, and a method for treatment of obstructive lung diseases
Bense, Laszlo 1207883*
Use of CGRP anatgonists and CGRP release inhibitors for controlling menopausal hot flashes
Boehringer Ingelheim Pharma 1207884*
Dietary supplement energy-providing to skeletal muscles and protecting the gastrointestinal tract
Sigma-Tau Healthcare 1207885*
Sphingomyelinase inhibitor
Universitaet Heidelberg; Technoligie-Lizenz-Buero (TLB) Der Baden-Wurttembergischen Hochschulen 1207886*
Use of hepoxilins or hepoxilin analogues as antidiabetic, antiinflammatory agents
HSC Research and Development 1207887*
Use of paclitaxel and of steroid derivatives as aromatase inhibitors for the treatment of cancer
Sterix 1207888*
Antiviral prodrugs
ICN Pharmaceuticals 1207890*
Use of a low molecular weight sulphated polysaccharide to obtain a medicine with antithrombotic activity
Institut Francais de Recherche pour l'Exploitation de la Mer; Centre National de la Recherche Scientifique; Universite Rene Descartes 1207891*
Use of oyster flesh enzymatic hydrolysates for preparing compsns eliminating free radicals
Institut Francais de Recherche pour l'Exploitation de la Mer; Assistance Publique, Hopitaux de Paris 1207892*
Wound healing article comprising dried and crushed leaves from Plantago Major
Larson, Bjornar 1207893*
A synergistic compsn for the treatment of liver and liver associated ailments and a process for preparing the same
Rajgarhla, Ashok 1207894*
Peptide and peptide analogues for the treatment and prevention of diabetes
Virginia Mason Research Centre 1207895*
Methods and compsns for reducing serum phosphate levels
Big Bear Bio 1207896*
Pharmaceutical compsns containing tripeptides
Tripep 1207897*
Treatment of conjunctivitis
Evolutec 1207898*
Treatment of allergic rhinitis
Evolutec 1207899*
Dose of an angiogenic factor and method of administering to improve myocardial blood flow
Chiron 1207900*
Use of natriuretic peptides as antibiotically effective substances for treating bacterial infections
Pharis Biotec 1207901*
Use of growth hormone (HGH) for the treatment of sexual functional disturbances
Pharmacia 1207902*
Reduction of the immunogenicity of non-human grafts
Absorber 1207903*
New clinical parameters for determining hematological toxicity prior to radioimmunotherapy
Idec Pharmaceuticals 1207904*
Methods and compsns for treatment of immunomodulatory disease using cadherin-11 modulating agents
The Brigham and Women's Hospital 1207905*
Treatment of patients having non-Hodgkin's lymphoma with bone marrow involvement with anti-CD20 antibodies
Idec Pharmaceuticals 1207906*
Compsns for treating viral diseases, and methods therefor
University of Maryland Biotechnology Institute 1207907*
